Abstract
Clinical use of valid biomarkers enables the prediction of alloreactive response (risk of rejection) and personal susceptibility to immunosuppressive treatment could lead to personalized immunosuppressive therapy. In clinical transplantation, it has been reported that cytokine production and secretion could be modified by immunosuppressive drugs, as well as during the rejection process. Some cytokines such as interferon (IFN)-γ, interleukin (IL)-2, IL-10, and transforming growth factor (TGF)-β have been identified as candidate biomarkers that correlate with graft outcome and personal response to immunosuppressive agents. This review will focus on the current state of knowledge, indicating that monitoring changes in cytokine production could be used to predict the risk of rejection and to guide immunosuppression therapy in transplant recipients. In addition, many questions regarding the characteristics and standardization of the methods used for cytokine monitoring (ELISA; ELISPOT; Flow Cytometry) that need to be addressed before these assays can be clinically applied will be discussed in light of recent studies showing an association between the expression of some cytokines and genetic variants, the impact of immunosuppression,...Continue Reading
References
Sep 6, 2000·Transplantation·R PelletierC Orosz
Feb 13, 2001·Scandinavian Journal of Immunology·P F JørgensenA O Aasen
Apr 24, 2001·Transplant Immunology·K L PooleW M Howell
Sep 7, 2001·Transplantation·A B HahnD J Conti
Jan 28, 2003·Therapeutic Drug Monitoring·Mario StalderRandall E Morris
May 3, 2003·Transplant Immunology·D O McDanielD E Butkus
Jun 20, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Donald E HricikPeter S Heeger
Oct 28, 2003·Clinical Chemistry·Olga MillánJaume Martorell
Jun 30, 2004·Transplantation·Emmanuel BoleslawskiYvon Calmus
Sep 3, 2004·Nature Reviews. Immunology·Thomas R Malek, Allison L Bayer
Nov 18, 2004·Tissue Antigens·J-Y ParkC Ahn
Dec 14, 2004·Transplantation·Peter NickelPetra Reinke
Dec 16, 2004·Transplantation·Noora S AlakulppiJarmo T Laine
Feb 4, 2005·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Michiel C WarléHugo W Tilanus
May 25, 2005·Transplantation·Jian-Guo ChaiJulian Dyson
Feb 16, 2006·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Markus J BartenJan F Gummert
Apr 14, 2006·Kidney International·P Pribylova-HribovaJ Lacha
Feb 17, 2007·Therapeutic Drug Monitoring·Torsten BöhlerJochen Klupp
Aug 21, 2007·Molecular Diagnosis & Therapy·Mercè BrunetOlga Millán
Feb 28, 2008·Transplantation·Nancy L ReinsmoenKay Savik
Apr 18, 2008·Journal of the American Society of Nephrology : JASN·Oriol BestardPetra Reinke
Aug 12, 2008·Cell·Ming O Li, Richard A Flavell
Nov 27, 2008·Transplant Immunology·Peter NickelPetra Reinke
Mar 20, 2009·Clinical and Experimental Medicine·Bora AkogluDominik Faust
Mar 2, 2011·European Journal of Clinical Pharmacology·Xiaoqing ZhangZhihai Peng
Jun 11, 2011·Transplantation·Diana M GirnitaAdriana Zeevi
Citations
Mar 8, 2013·Future Medicinal Chemistry·Makio Iwashima, Robert Love
Sep 17, 2014·Biomarkers in Medicine·Jenna F McMinnRoy S Gardner
Mar 8, 2016·Talanta·Gozde BaydemirDiego Voccia
Oct 30, 2012·Transplant Immunology·Sasivimol RattanasiriAmmarin Thakkinstian
Oct 8, 2015·Therapeutic Drug Monitoring·Brunet MercèLópez-Hoyos Marcos
Dec 4, 2014·Analytica Chimica Acta·Julie A Stenken, Andreas J Poschenrieder
Feb 23, 2018·Frontiers in Immunology·Hongyan HouZiyong Sun
Aug 7, 2014·Journal of the American Society of Nephrology : JASN·Mark D StegallArthur Matas
Sep 3, 2013·Current Opinion in Organ Transplantation·Clara Crescioli
May 24, 2020·Sensors·Sunil K Arya, Pedro Estrela
Sep 3, 2016·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Zhiwei ZhangXin Song
Dec 5, 2018·Journal of Immunology Research·Esmaeil MortazGert Folkerts